Neurocrine Biosciences | 营业费用

Operating Expenses 更改 日
AbbVie USD 9.35B 1.76B 2024-03
Acadia Pharmaceuticals USD 190.62M 5.48M 2024-03
Agios Pharmaceuticals USD 100.26M 13.12M 2024-03
ALKERMES USD 307.06M 15.78M 2024-03
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Amgen USD 6.46B 469M 2024-03
Biogen USD 1.72B 306.9M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Cytokinetics USD 127.07M 2.02M 2024-03
Dynavax Technologies USD 68.56M 4.47M 2024-03
Exelixis USD 362.93M 126.57M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
Halozyme Therapeutics USD 100.34M 28.67M 2024-03
Incyte USD 789.54M 36.54M 2024-03
Intra Cellular Therapies USD 165.8M 401K 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Prothena USD 81.58M 2.75M 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Repligen USD 148.61M 20.69M 2024-03
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
Teva Pharmaceutical Industries USD 3.18B 525M 2024-03
Ultragenyx Pharmaceutical USD 274.18M 24.74M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03



Neurocrine Biosciences 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.